When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MACK - Merrimack Pharmaceuticals GAAP EPS of -$0.01
Merrimack Pharmaceuticals Inc.
Merrimack Pharmaceuticals press release (NASDAQ:MACK): Q1 GAAP EPS of -$0.01. “During the first quarter of 2022 we continued to see reductions in our operating expenses and were able to close the sale of an additional preclinical asset” said Gary Crocker, Chairman of Merrimack's Board of Directors. “We continue to be focused on maintaining cash balances that will allow us to be in a position to receive milestone payments from Ipsen and Elevation if the programs that we have licensed to them continue to progress.”